AAAAAA
Results:
1-15
|
Results: 15
Authors:
Ruggeri, M
Tosetto, A
Castaman, G
Rodeghiero, F
Citation: M. Ruggeri et al., Pulmonary embolism after pregnancy in a patient with polycythemia Vera, AM J HEMAT, 67(3), 2001, pp. 216-217
Authors:
Castaman, G
Tosetto, A
Simioni, M
Ruggeri, M
Madeo, D
Rodeghiero, F
Citation: G. Castaman et al., Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis, THROMB HAEM, 86(3), 2001, pp. 804-808
Congenital absence of the inferior vena cava: a rare risk factor for idiopathic deep-vein thrombosis
Authors:
Ruggeri, M
Tosetto, A
Castaman, G
Rodeghiero, F
Citation: M. Ruggeri et al., Congenital absence of the inferior vena cava: a rare risk factor for idiopathic deep-vein thrombosis, LANCET, 357(9254), 2001, pp. 441-441
Authors:
Ruggeri, M
Castaman, G
Tosetto, A
Rodeghiero, F
Citation: M. Ruggeri et al., Two families with combined homozygous/heterozygous factor V Leiden mutation and heterozygous G20210A factor II variant, BL COAG FIB, 11(8), 2000, pp. 783-784
Authors:
Castaman, G
Tosetto, A
Cappellari, A
Ruggeri, M
Rodeghiero, F
Citation: G. Castaman et al., The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency, BL COAG FIB, 11(4), 2000, pp. 321-326
Authors:
Tosetto, A
Castaman, G
Cappellari, A
Rodeghiero, F
Citation: A. Tosetto et al., The VITA project: Heritability of resistance to activated protein C, THROMB HAEM, 84(5), 2000, pp. 811-814
Authors:
Castaman, G
Ruggeri, M
Tosetto, A
Rodeghiero, F
Citation: G. Castaman et al., Heterogeneity of activated protein C resistance phenotype in subjects withcompound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene, THROMB HAEM, 84(2), 2000, pp. 357-358
Authors:
Tosetto, A
Missiaglia, E
Frezzato, M
Rodeghiero, F
Citation: A. Tosetto et al., The VITA Project: Prothrombin G20210A mutation and venous thromboembolism in the general population, THROMB HAEM, 82(5), 1999, pp. 1395-1398
Authors:
Ruggeri, M
Tosetto, A
Rodeghiero, F
Finazzi, G
Barbui, T
Citation: M. Ruggeri et al., The management of 'low-risk' and 'intermediate-risk' patients with primarythrombocythaemia, BR J HAEM, 106(3), 1999, pp. 834-834
Authors:
Castaman, G
Tosetto, A
Ruggeri, M
Rodeghiero, F
Citation: G. Castaman et al., Pseudohomozygosity for activated protein C resistance is a risk factor forvenous thrombosis, BR J HAEM, 106(1), 1999, pp. 232-236
Authors:
Rodeghiero, F
Tosetto, A
Citation: F. Rodeghiero et A. Tosetto, Risk factors for thromboembolism - Response, ANN INT MED, 131(10), 1999, pp. 790-791
Authors:
Rodeghiero, F
Tosetto, A
Citation: F. Rodeghiero et A. Tosetto, Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism, ANN INT MED, 130(8), 1999, pp. 643
Authors:
Palareti, G
Dettori, AG
Ciavarella, N
Manotti, C
Baudo, F
Berrettini, M
Finazzi, G
Marongiu, F
Pengo, V
Prisco, D
Tosetto, A
Tripodi, A
Citation: G. Palareti et al., A guide to oral anticoagulant therapy, HAEMOSTASIS, 28, 1998, pp. 1-46
Authors:
Ruggeri, M
Finazzi, G
Tosetto, A
Riva, S
Rodeghiero, F
Barbui, T
Citation: M. Ruggeri et al., No treatment for low-risk thrombocythaemia: results from a prospective study, BR J HAEM, 103(3), 1998, pp. 772-777
Authors:
Tosetto, A
Rodeghiero, F
Martinelli, I
De Stefano, V
Missiaglia, E
Chiusolo, P
Mannucci, PM
Citation: A. Tosetto et al., Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation, BR J HAEM, 103(3), 1998, pp. 871-876
Risultati:
1-15
|